Tech Company Financing Transactions
XTuit Pharmaceuticals Funding Round
Polaris Partners and private investors participated in a $4 million funding round for XTuit Pharmaceuticals. This venture round was recorded on 12/31/2014.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
35 Gatehouse Dr. A1
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
XTuit Pharmaceuticals, Inc. is a biopharmaceutical company developing novel microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Crane
Chief Scientific Officer
Peter Blume-Jensen
Browse more venture capital transactions:
Prev: 12/31/2014: HDL Therapeutics venture capital transaction
Next: 12/31/2014: Cobalt Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs